Prolonged Tracheal Intubation and the Association Between Patent Ductus Arteriosus and Bronchopulmonary Dysplasia: A Secondary Analysis of the PDA-TOLERATE trial.
Document Type
Article
Publication Date
10-27-2020
Publication Title
The Journal of pediatrics
Abstract
In the PDA-TOLERATE trial, persistent (even for several weeks) moderate to large patent ductus arteriosus (PDA) was not associated with an increased risk of BPD when the infant requiredHowever, in infants requiring intubation for ≥10 days, prolonged PDA exposure (≥11 days) was associated with an increased risk of moderate/severe BPD.
Clinical Institute
Women & Children
Department
Pediatrics
Recommended Citation
Clyman, Ronald I; Kaempf, Joseph; Liebowitz, Melissa; Erdeve, Omer; Bulbul, Ali; Håkansson, Stellan; Lindqvist, Johanna; Farooqi, Aijaz; Katheria, Anup; Sauberan, Jason; Singh, Jaideep; Nelson, Kelly; Wickremasinghe, Andrea; Dong, Lawrence; Hassinger, Denise C; Aucott, Susan W; Hayashi, Madoka; Heuchan, Anne Marie; Carey, William A; Derrick, Matthew; Fernandez, Erika; Sankar, Meera; Leone, Tina; Perez, Jorge; Serize, Arturo; and PDA-TOLERATE Trial Investigators, "Prolonged Tracheal Intubation and the Association Between Patent Ductus Arteriosus and Bronchopulmonary Dysplasia: A Secondary Analysis of the PDA-TOLERATE trial." (2020). Articles, Abstracts, and Reports. 3790.
https://digitalcommons.providence.org/publications/3790
